Using Immersive Virtual Reality for the Upper Limb Rehabilitation of Post-stroke Subjects
1 other identifier
interventional
48
1 country
1
Brief Summary
Stroke produces brain damages that results in sensory, motor, and cognitive impairments which reduce the patient's quality of life and social participation. Upper limb recovery is a complex process whose goal is to allow the patients to gain, in part or completely, independence in daily living activities, for that it represents one of the most important rehabilitation focus. Virtual reality is a fairly recent approach able to simulate concrete movements and functional tasks in a higher dosage compared to other therapies. It seems that the use of VR could improve limb function, however, the amount of this gain is still unclear because of insufficient evidence. This study aims at quantitatively investigating the effectiveness of an HMD immersive virtual reality system on the upper limb functioning in subacute stroke survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 30, 2023
CompletedStudy Start
First participant enrolled
March 1, 2023
CompletedFirst Posted
Study publicly available on registry
March 25, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedMarch 25, 2025
November 1, 2024
2.8 years
January 30, 2023
March 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in upper limb impairment
Motor recovery will be assessed through the Fugl Meyer Assessment - Upper Extremity
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Secondary Outcomes (8)
Change in Spasticity
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Change in Activities of Daily Living
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Change in perceived quality of life
Score changes before (T0) and after (T1) the 4 weeks of treatment and at 6-month follow-up (T2)
Kinematic data
Parameters changes (e.g. hand peak velocities) before (T0) and after (T1) the 4 weeks of treatment
Electroencephalogram
Data changes before (T0) and after (T1) the 4 weeks of treatment (4 weeks) and at 6-month follow-up (T2)
- +3 more secondary outcomes
Study Arms (2)
VR group
EXPERIMENTALAll participants will receive an hour of VR training 5 times/week for 4 weeks within the daily rehab routine.
Control group
NO INTERVENTIONParticipants will receive the usual rehabilitation activities due to their clinical needs (physical therapy, speech therapy, etc) for 5 times/week over 4 weeks.
Interventions
Four tasks, uni and bi-manuals, will be proposed for the treatment of the patient's paretic upper limb in virtual-apartment for improving the relevance and the transferability of the movements requested.
Eligibility Criteria
You may qualify if:
- diagnosis of first, ischemic or hemorrhagic, stroke verified by brain imaging within 4 week
- upper limb motor impairment defined by an upper extremity score \<55 on the Fugl-Meyer Assessment
You may not qualify if:
- neurological conditions in addition to stroke that may affect motor function
- other medical conditions likely to interfere with the ability to safely complete the study protocol
- impaired cognitive functioning that influences the ability to give informed consent
- severe neuropsychological disorders
- visual impairment
- severe upper-limb pain defined as \> 7 on the Visual Analogue Scale
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital of Ferraralead
- Ospedale Accreditato Villa Bellombracollaborator
- Casa di Cura Città di Rovigocollaborator
- IRCCS Centro Neurolesi Bonino Pulejocollaborator
Study Sites (1)
Ferrara University Hospital
Ferrara, 44124, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- The randomization scheme will be generated using the website http://www.randomization.com and managed by an external administrator. The clinicians who will perform the outcome assessment will be blind regarding the subject's group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 30, 2023
First Posted
March 25, 2025
Study Start
March 1, 2023
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
March 25, 2025
Record last verified: 2024-11